[Federal Register Volume 65, Number 27 (Wednesday, February 9, 2000)]
[Notices]
[Page 6396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2872]



[[Page 6396]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 6, 1999, 
Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 
63147, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
dihydromorphine (9145), a basic class of controlled substance listed in 
Schedule I.
    Mallinckrodt, Inc. plans to isolate dihydromorphine as a step in a 
multistep synthesis of hydromorphone.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than (April 10, 2000).

    Dated: January 28, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-2872 Filed 2-8-00; 8:45 am]
BILLING CODE 4410-09-M